Sat, 28th August, 2010 | (0) Comment
A new study comparing heart side effects risks of rival diabetes drugs Avandia and Actos suggests both treatments carry similar risks of heart attack, acute heart failure and death.
Researchers at health insurance company WellPoint reviewed the claims records of over 29,000 diabetic clients who took either of the drugs between 2001 and 2005. The study was published on August 24, 2010 in the medical journal, “Circulation: Cardiovascular Quality and Outcomes.” Continue reading Avandia heart risks similar to Actos claims new study
Wed, 25th August, 2010 | (0) Comment
Heart failure is a condition in which the can’t pump enough blood to meet the body’s needs.
Congestive heart failure (CHF) is a chronic cardiovascular disease process and may cause disability and even death. Use of the Type 2 diabetes drug Avandia has been linked to an increased risk of congestive heart failure (CHF) and death. Continue reading Avandia Heart Failure Lawsuit Settlements
Tue, 10th August, 2010 | (0) Comment
A new law has been been proposed to give the FDA authority to recall dangerous drugs.
Currently, the FDA can only require warnings, issue safety alerts and recommend that a dangerous drug be recalled. The Drug Safety and Accountability Act of 2010 would give the FDA power to recall drugs it determines to be unsafe. Continue reading New law would give FDA drug recall power
Sat, 31st July, 2010 | (0) Comment
Avandia increases the risk of fractures in women over 50 and in men who also take loop diuretics, according a new study published in the Journal of Clinical Endocrinology & Metabolism.
The new study examined diabetes treatments and fractures using data from the TRIAD study of diabetic patients in managed care settings. Continue reading New study links TZDs Actos and Avandia to fracture risk
Tue, 27th July, 2010 | (0) Comment
FDA puts Avandia drug safety TIDE trial on clinical hold pending Avandia side effects risks review.
The FDA has given notice to Avandia drug manufacturer GlaxoSmithKline that the TIDE trial has been put on clinical hold pending review of Avandia safety information presented at the FDA Advisory Committee meeting on Avandia drug safety held July 13 and 14, 2010. The complete FDA statement is set out in full. Continue reading FDA Statement on Avandia TIDE Trial
Tue, 27th July, 2010 | (0) Comment
A heart attack is the sudden death heart cells due to inadequate blood flow to part of the heart.
A heart attack occurs when blood supply to an area of the heart is cut off by a clot blocking coronary artery blood flow to the heart. Heart damages caused by heart attack oxygen deprivation can rapidly lead to permanent disability and death. Use of the Type 2 diabetes drug Avandia has been linked to an increased risk of heart attack. Continue reading Avandia Heart Attack Lawsuit
Sun, 25th July, 2010 | (0) Comment
A stroke is the sudden death of brain cells due to inadequate blood flow to part of the brain.
A stroke occurs when blood flow to an area of the brain is cut off by a blockage or rupture of a blood vessel to or within the brain. Damage to brain cells caused by stroke-related oxygen deprivation can rapidly lead to permanent disability and death. Use of the Type 2 diabetes drug Avandia has been linked to an increased risk of stroke. Continue reading Avandia Stroke Lawsuit